# Lilly to acquire cancer drug developer Kelonia for up to $7B.

*biotech · news · 2026-04-20 · Seeking Alpha*

## Key points

- Eli Lilly will acquire Kelonia Therapeutics for up to $7 billion in cash.
- Kelonia Therapeutics is a privately held company focused on developing cancer drugs.
- The acquisition confirms earlier reporting by The Wall Street Journal.
- This move signals Lilly's further expansion into cancer drug development.

**Companies:** Eli Lilly and Company

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4576611-lilly-to-buy-cancer-biotech-kelonia-up-7b)

---

Canonical: https://newsio.io/n/ac0d9242-80fb-4465-9033-89062986a9b9/lilly-to-acquire-cancer-drug-developer-kelonia-for-up-to-7b
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works